Coxiella burnetii (Q-Fever) Phase 2 IgG ELISA EIA-5189

GUDID 00404847451894

The Coxiella burnetii (Q-Fever) Phase 2 IgG ELISA is intended for the qualitative determination of IgG class antibodies against Coxiella burnetii (Q-Fever) Phase 2 in human serum or plasma (citrate, heparin).

DRG Instruments Gesellschaft mit beschränkter Haftung

Coxiella burnetii immunoglobulin G (IgG) antibody IVD, kit, enzyme immunoassay (EIA)
Primary Device ID00404847451894
NIH Device Record Key747896c4-56fd-4427-abde-58d9ebf24952
Commercial Distribution StatusIn Commercial Distribution
Brand NameCoxiella burnetii (Q-Fever) Phase 2 IgG ELISA
Version Model NumberEIA-5189
Catalog NumberEIA-5189
Company DUNS317134468
Company NameDRG Instruments Gesellschaft mit beschränkter Haftung
Device Count1
DM Exemptfalse
Pre-market Exempttrue
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datetrue
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com
Phone+1(973)564-7555
Emailcorp@drg-international.com

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS100404847451894 [Primary]

FDA Product Code

GPRANTISERUM, CF, Q FEVER

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2021-06-15
Device Publish Date2021-06-07

On-Brand Devices [Coxiella burnetii (Q-Fever) Phase 2 IgG ELISA]

00404847451894The Coxiella burnetii (Q-Fever) Phase 2 IgG ELISA is intended for the qualitative determination
04048474051896The Coxiella burnetii (Q-Fever) Phase 2 IgG ELISA is intended for the qualitative determination

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.